Swissana Clinic AG has been acquired by Hirslanden AG
The private shareholders of Swissana Clinic AG have sold the company to Hirslanden AG for an undisclosed consideration.
Swissana Clinic AG was founded in 1995 and is one of the leading independent hospitals in central Switzerland. It is equipped with three operating rooms, offers 20 in-patient beds with first class comfort and a day hospital with 11 beds.
Hirslanden is the leading group of private hospitals in Switzerland and operates 16 facilities throughout the country. It is owned by Medi-Clinic International, a listed company from South Africa.
Oaklins' team in Switzerland advised the sellers on the preparation of the divestment process and due diligence, the approach and negotiations with potential buyers, and assisted them until closing.


Talk to the deal team
Related deals
Bolster Investment Partners has acquired a majority stake in Eternal Sun
Bolster Investment Partners, a Netherlands-based investment firm, has acquired a majority stake in Eternal Sun, a global technology leader in advanced solar panel testing equipment, from ABN AMRO Sustainable Impact Fund, a private impact fund based in the Netherlands, and Vermec, a Belgium-based investment firm.
Learn moreCerbios-Pharma has been acquired by HAS Healthcare
Cerbios-Pharma S.A. has been acquired by HAS Healthcare Advanced Synthesis S.A., forming a leading global contract development and manufacturing organization (CDMO) group. This transaction results in a seamless integration of complementary capabilities, combining extensive expertise in production, chemical and biological sciences and technical excellence, all designed to meet the evolving demands of the global pharmaceutical sector.
Learn moreiwell raises US$31 million to deploy its leading European smart battery storage solutions into new markets
iwell, a developer of smart energy management (EMS) and battery storage systems (BESS), has successfully closed a US$31 million (€27 million) funding round. The round was led by Meridiam, with Invest-NL and Rabobank participating, alongside existing investors.
Learn more